drugset / Trial / NCT07444294
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
RandomizedSequentialQuadruple-blindTreatment
Summary
A phase 1 study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of SRK-439 in healthy adults
Timeline
- Start
- 2025-11-21
- Primary completion
- 2026-12-17
- Completion
- 2027-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SRK-439 | Unknown | — | Subcutaneous |
Indications
No indication recorded.